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Background: Inflammatory reaction in blood–spinal cord barrier (BSCB) plays a crucial role in ischemia/reperfusion
(I/R) injury. It has been shown that microglia could be activated through Toll-like receptors (TLRs). Therefore, we
hypothesize that TLR4 is involved in the microglial activation and BSCB disruption after I/R.
Results: To verify our hypothesis, we analyzed the behavioral data, changes of BSCB permeability, as well as
expressions of microglial marker Iba-1 and TLR4 in spinal cord I/R model induced by 14 min aortic occlusion. Double
immunostaining reveals that after I/R, Iba-1 immunoreactivity increased gradually 12 h after reperfusion and
maintained at a such level throughout 36 h. Such increasing pattern of Iba-1 expression is consistent with the
increases in Evan’s Blue (EB) extravasation, spinal water content and mechanical allodynia demonstrated by lowed
withdrawal threshold to Von Frey filaments. Moreover, double immunostaining suggested that TLR4 was highly
expressed in microglia. Intrathecal infusion of minocycline and TAK-242 (TLR4 inhibitor) treatment attenuated I/R-induced
allodynia and BSCB leakage. In contrast, LPS induced TLR4 expression aggregated above-mentioned injuries. Furthermore,
the nuclear factor-kappa B (NF-κB) activity has a similar profile as TLR4 activity. It is consisted with the results of NF-κB
mRNA and protein expression changes and activation of downstream cytokine, IL-1β. Expectedly, intrathecal infusion of
pyrrolidine dithiocarbamate (PDTC), a NF-κB inhibitor, showed similar protective effects as minocycline and TAK-242. In
addition, our data show that TLR4 closely involved in I/R-induced inflammatory damage induced neuronal apoptosis.
Significantly, neutralizing TLR4 function largely reduced neuronal apoptosis determined by NeuN immunoreactivity in
ventral gray matter and increased percentage of double-label cells with cleaved caspase3, whereas LPS reversed these
effects. Similarly, inhibitions of microglia and NF-κB with minocycline or PDTC treatment accordingly perform the same
protective effects on I/R injury.
Conclusion: The results indicate that compromised BSCB caused by I/R injury lead to spinal microglial activation and
TLR4, its membrane-bound receptor, up-regulation, which then initiate neuro-inflammation and neuro-apoptosis via
NF-κB/ IL-1β pathway. To inhibit the positive feedback loop of TLR4-microglia-NF-κB/ IL-1β pathway by minocycline,
TAK-242 (TLR4 inhibitor) and pyrrolidine dithiocarbamate (PDTC, NF-κB inhibitor) may provide new targets for treating I/R
injury in clinic.
Keywords: Blood–spinal cord barrier, Intrathecal transplantation, Microglia, Minocycline, Toll-like receptor 4, Spinal cord
ischemia/reperfusion injury* Correspondence: mahong5466@yahoo.com
Department of Anesthesiology, First Affiliated Hospital, China Medical
University, Shenyang 110001, Liaoning, China
© 2014 Li et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Li et al. Molecular Brain 2014, 7:28 Page 2 of 14
http://www.molecularbrain.com/content/7/1/28Background
Spinal cord ischemia/reperfusion (I/R) injury is the most
devastating complications encountered in many patho-
physiological situations, such as hypotension, surgical
procedures on thoracic, thoracoabdominal aneurysms
and the spine [1]. It remains as a widespread and persistent
problem, because its debilitating injuries to the central
nervous system results in high incidence of paraplegia
posing a serious threat to patients. However, the underlie
mechanism of spinal cord I/R injury is not well under-
stood. This is probably due to the induction of spinal cord
I/R injury is multifactorial [2-4]. Blood–spinal cord barrier
(BSCB), surrounded by astrocytes and perivascular micro-
glia, consists of a continuous capillary endothelium with
tight junctions between the cells. As shown in our previous
studies, BSCB disruption and inflammatory reactions play
an important role in the evolution of spinal cord I/R injury
and in promotion of neuronal damage [5,6]. Research has
expanded into the glial/neuronal transmission and immune
responses of resident glial cells to spinal cord injury [7,8].
Existing evidence shows that spinal glial activation involves
important components of the immune system and triggers
rapid signal transduction cascades of the transcription-
factor nuclear factor κB (NF-κB), driving gene expression
of proinflammatory cytokines (e.g. IL-1β) in the course of
pathophysiological changes that occur after brain injury
[9]. Nonetheless, the specific cellular source within micro-
glia which is responsible for transferring immune stimuli
into the nervous system responses is unknown. During the
pathogenic cascade after central nervous system (CNS)
injury, microglia are thought to be the first nonneuronal
cells to express a plethora of growth factors, chemokines,
and regulatory cytokines as well as free radicals and other
toxic mediators [7,10].
In microglia, Toll-like receptors (TLRs), especially TLR4,
have been shown to recognize various microbial products
and to initiate innate immune responses upon interaction
with infectious agents or endogenous ligands present in
the spinal cord in vivo and in vitro [10,11]. The general
understanding is that TLR4 can be specifically activated
to initiate immune responses by presenting a pathogen-
derived antigen to naïve T cells when sensing lipopolysac-
charide (LPS), a common constituent in the cell wall of
Gram-negative bacteria [12].Studies have demonstrated
that TLR4 is upregulated in different I/R-injured organs, in-
cluding heart, brain, liver, and kidney [13,14]. Nevertheless,
the relationship between TLR4 and microglial activation in
spinal cord I/R injury remains unknown. Thus, we hypoth-
esized that there might be a link between TLR4 of micro-
glia to the stressors that damaged neurons: endogenous
antibodies or cytokines that leaked through disrupted
BSCB, which, in turn, contributes to further activation of
microglia and BSCB disruption. Moreover, recent studies
suggest that microglia activation which could be inhibitedby minocycline is a double-edged sword in various
neurological models and under different conditions
[8,15]. Ischemia was regarded as a powerful stimulus
that disabled the endogenous inhibitory signaling and
triggered microglial activation [7]. Upon activation, micro-
glia could exhibit plenty of phenotypes and release both
pro- and anti-inflammatory mediators to either exacerbate
ischemic injury or help repair. A few studies, however, have
conducted on the spinal cord model of I/R injury and state
that whether activation of microglia is deleterious and/or
beneficial for spinal cord recovery is still a controversial
topic. To testify our hypothesis, we first explore whether
microglia are activated in a rat model of spinal cord I/R
injury. Next, we evaluate the roles of TLR4 and NF-κB
during I/R-induced BSCB disruption with and without the
involvement of microglia.
Results
Alterations in the neurological deficit after I/R
As illustrated in Figure 1, the weights of rats significantly
decreased relative to baseline in withdrawal thresholds
(WTs) to Von Frey filaments throughout 36 h after reper-
fusion in I/R group (P < .05), indicating the development
of mechanical allodynia is induced by 14 min thoracic
aortic occlusion. Moreover, WTs of I/R group were much
lower than those of intrathecally administrated minocy-
cline treated group (I/R + M group), TLR4 inhibitor
treated group (I/R + T group) and PDTC treated group
(I/R + P group). On the other hand, WTs of I/R group
were higher than those of LPS induced group (I/R + L
group) throughout all observed time points postopera-
tively (P < .05). There were no significant differences
between I/R + M group, I/R + T group and I/R + P
group at above time points (P > .05).
Effects of I/R on BSCB permeability
As shown in Figure 2A and B, BSCB permeability was
changing in response to spinal cord I/R injury. BSCB
permeability is visualized by extravasation of the Evans
blue (EB) dye. I/R induced marked increase in the amount
of EB extravasation comparing to the sham groups at 12
and 36 h after reperfusion (P < .01). Intrathecal infusion of
minocycline, TAK-242 and PDTC (to suppress microglial
activation, TLR4 and NF-κB function, respectively) reduce
the EB content and the percentage of strained area at 12
and 36 h after the surgical procedure (P < .01 compared to
the I/R group). In contrast, intrathecal infusion of LPS, a
TLR4 agonist, synergized the BSCB leakage as the
increased EB content and the percentage of strained area
(P < .05 compared to I/R group). Quantification of the EB
content of the injured spinal cord in Figure 2C confirmed
that BSCB leakage induced by I/R injury was synergistic-
ally increased by LPS (P < .05 ) and was attenuated by
minocycline, TAK-242 and PDTC treatments (all P < .01).
Figure 1 Alterations in neurological deficits in mechanical sensitivity to von Frey filaments after spinal cord ischemia reperfusion (I/R)
injury. The significant decreases relative to baseline in withdrawal threshold (WT) on postoperative 8 h to 36 h in I/R group, suggesting that
spinal cord I/R injury induced mechanical hyperalgesia in the paws. Continuous intrathecal administration of minocycline, TAK-242 and pyrrolidine
dithiocarbamate (PDTC) for 3 days before the surgical operation increased the withdrawal threshold at time points 8, 12, 24, and 36 h compared
to the I/R group. Intrathecal administration of LPS synergistically enhanced the mechanical hyperalgesia. **P < .01 compared to Sham group;
##P < .05 compared to I/R group in one-way analysis of variance followed by Tukey’s test (n = 12 per group).
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between the groups of I/R + M, I/R + T and I/R + P at all
above time points (P > .05).
Furthermore, assessment of water content showed similar
results as indicated in Figure 2D. I/R increased water content
due to spinal cord edema (P < .01), and intrathecal infusion
of minocycline, TAK-242 and PDTC markedly attenuatedFigure 2 Alterations in blood–spinal cord barrier (BSCB) integrity afte
cord I/R injury on BSCB permeability measured by Evans blue (EB) extravas
group at 12 and 36 h after injury. Much more red fluorescence, especially i
was even stronger at 36 h postoperatively. And EB red extravasation was signif
PDTC, whereas EB extravasation was worsen by intrathecal injection with LPS a
of the spinal cord (μg/g). (D) Quantification of the water content of the spinal
Scale bars are 200 μm. **P< .01 compared to Sham group; ##P < .05 comparedthis effect at 12 and 36 h (P < .05), whereas treatment with
LPS synergistically increased spinal cord edema (P < .05) .
Effects of I/R on Microglial reaction in the spinal cord
As shown in Figure 3A and B, the fluorescence inten-
sities of ionized calcium–binding adaptor molecule 1
(Iba-1) are commonly used to quantify activated microglia.r spinal cord ischemia reperfusion I/R injury. (A) Effects of spinal
ation. Almost no red fluorescence was seen in spinal cord of Sham
n the gray matter could be seen in I/R group at 12 h after injury, which
icantly weakened in the groups pretreated with minocycline, TAK-242 and
t above time points. (B) Percentage of EB extravasated area. (C) EB content
cord (edema). All data are presented as mean ± SEM (n = 8 per group).
to I/R group.
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ramified shape (Figure 3A-a, b) to a rounded (amoeboid)
macrophage-like shape. As shown in our study, typical
activated microglia with Iba-1 staining exhibited hyper-
trophic morphology, with thick processes which could easily
be distinguished from the inactivated ones ( Figure 3A-c,d).
In contrast to sham-operated rats, remarkably increased
immunoreactivity to Iba-1 was observed in both sides of
L4–6 spinal cord in I/R group rats (Figure 3B, P < .05).
In addition, the increased Iba-1 immunoreactivity promin-
ent in the dorsal horns obviously inhibited in rats precon-
ditioning with minocycline, TAK-242 or PDTC, however,
increased in those receiving LPS (all P < .05). Figure 3C
showed the quantitative measurement of the cells that
were positive for Iba-1 staining recorded for each speci-
men in a blind fashion at 12 h and 36 h after I/R injury.
The data showe that pretreatment with minocycline be-
fore ischemia significantly prevented the microglial activa-
tion and proliferation during a 36-h follow-up period after
reperfusion (P < .01). Interestingly, neutralizing functionFigure 3 Alterations in microglial reaction after spinal cord ischemia
microglia after spinal cord after I/R injury. Scale bars are 200 μm in 3A a, c;
I/R injury. Scale bars are 200 μm. (C) Quantification of Iba-1–positive cells in
group).Prominent Iba-1 positive cells activated by I/R injury were observed
who exhibited hypertrophic morphology with thick processes. Increases in
dorsal horn were markedly attenuated by intrathecal injection of minocycli
compared to Sham group; ##P < .05 compared to I/R group.against TLR4 and NF-κB by intrathecal infusion of TAK-
242 and PDTC also significantly attenuated the microglial
activation indicated by the decreased number of Iba-1
positive cells (P < .01). In contrast, many more Iba-1
positive cells were observed in spinal cord of rats pre-
treated with LPS at the same time point (P < .01). There
were no significant differences between the groups of I/R +
M, I/R + T and I/R + P at above time points (P > .05).
Effects of I/R on expression and colocalization of TLR4
and microglial marker Iba-1 in the spinal cord
To investigate whether TLR4 was involved in I/R-induced
microglial activation and to determine its function, we
performed double immunofluorescent staining at 12 and
36 h after reperfusion. As shown in Figure 4A, TLR4 with
the identical fluorescence label were colocalized with the
distribution of Iba-1–positive microglia in I/R group rats,
but not in sham-operated ones. Thus, the data confirmed
that TLR4 was involved in microglial activation after I/R
injury (P < .05). Pretreated with TAK-242 to neutralizereperfusion (I/R) injury. (A) Effects on the morphology changed in
50 μm in 3A-b, d; (B) Effects on spinal immunoreactivity to Iba-1 after
the spinal cord’s dorsal horn is presented as mean ± SEM (n = 6 per
in both spinal dorsal horns of rats subjected to the surgical operation,
Iba-1 immunoreactivity and number of Iba-1–positive cells in spinal
ne, TAK-242 and PDTC but was synthetically activated by LPS. **P < .01
Figure 4 Double immunostaining of microglial cells with its membrane-bound receptor TLR4 after spinal cord ischemia reperfusion (I/R) injury.
(A) Representative micrographs show the cellular location of Toll-like receptor (TLR4; red) with antibodies against microglial specific marker (Iba-1; green) at
12 h and 36 h after I/R injury. Arrows delineate co-localization. Scale bars are 100 μm. (B) Histogram for quantification of co-localized cells (cells with yellow
signals). (C) Quantification of the TLR4 immunoreactivity is presented as average of three fluorescence intensity (FI) of three independent experiments. Double
immunohistochemistry showed TLR4 was highly expressed on spinal microglial after I/R injury. The rats pretreated with minocycline, TAK-242, PDTC were
suggested significantly decreased TLR4 immunoreactivity after I/R and the number of TLR4-Iba-1 positive microglia, whereas above effects synthetically
increased in rats receiving LPS. All data are presented as mean ± SEM (n = 8 per group). **P< .01 compared to Sham group; ##P< .05 compared to I/R group.
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reactivity, whereby up-regulation with TLR4 expression by
LPS largely increased Iba-1 immunoreactivity (Figure 4A,
P < .05). Similar quantification of TLR4 co-localization in
Figure 4B and TLR4 immunoreactivity in Figure 4C
confirmed that TLR4 was necessary for the I/R-induced
up-regulation of Iba-1 expression in activated microglial.
Additionally, there were no significant differences in the
amount of double-labeled cells, Iba-1 or TLR4 immunore-
activity betweens the groups of I/R + M, I/R + T and I/R +
P at above time points (Figure 4B and C, P > .05)
Effects of I/R on Neuronal reaction in the spinal cord
To determine whether TLR4 was involved in I/R-induced
inflammatory damage due to neurological deficit or neur-
onal apoptosis most likely, we performed double immuno-
fluorescent staining of neuronal-specific marker neuronal
nuclei (NeuN) and cleaved caspase3 at 12 and 36 h after
reperfusion. As shown in Figure 5A, comparing with
the sham group, there was remarkably decreased NeuNimmunoreactivity observed in ventral gray matter of rats
in I/R group (P < .05). In addition, the decreased NeuN
immunoreactivity was greatly prevented in rats precondi-
tioning with minocycline, TAK-242 or PDTC, nevertheless,
synthesized in those receiving LPS (all P < .05). The quanti-
fications of NeuN expressions were shown in Figure 5C.
Furthermore, double immunofluorescence in Figure 5B
showed that abundant capase-3 positive neurons in
spinal cord of rats in I/R group at both 12 h and 36 h,
and the amount r of double-labeled neurons was signifi-
cantly decreased in rats pretreated with minocycline,
TAK-242 or PDTC (all P < .05 ). In contrast, the neurons
had a higher density of co-staining with cleaved caspase3
in rats receiving LPS (P < .05). Quantification of the per-
centage of double-labels cells was shown in Figure 5D.
Effects on TLR4 -mediated NF-κB/IL-1β signal pathway in
spinal cord after I/R
The expression of TLR4 was measured to further investi-
gate its effect on microglial activation during I/R-induced
Figure 5 Alterations in Neuronal reaction after spinal cord ischemia reperfusion (I/R) injury. (A) Effects on spinal immunoreactivity to
neuronal marker NeuN in laminae IX of ventral gray matter after I/R injury. Scale bars are 200 μm. (B) Representative immunohistochemical
localization of neurons (NeuN; green) and cleaved caspase3 (red) in laminae IX of spinal cord at 12 h and 36 h after I/R injury. Arrows delineate
co-localization. Scale bars are 100 μm. (C) Quantification of the NeuN-positive neurons in laminae IX of ventral gray matter is presented as average
of three independent experiments. (D) Histogram of the values for co-localized cells (cells with yellow signals) as the percent of the total NeuN-positive
cells in laminae IX of ventral horn. Immunohistochemistry showed I/R led to the decrease in neuronal number of both spinal ventral horns and increase
percentage of NeuN-cleaved caspase3-positive cells, suggesting the loss of neurons partly as a result of apoptosis. Pretreated with minocycline, TAK-242,
PDTC were showed had neuroprotective effects as the decreases in number of neuronal apoptosis, intrathecal injection with LPS abrogated above
effects. All data are presented as mean ± SEM (n = 8 per group). **P< .01 compared to Sham group; ##P< .05 compared to I/R group.
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induced markedly increases protein and gene expressions
of TLR4 in comparison to sham group at 12 h and 36 h
after injury (P < .05). Pretreated with minocycline, TAK-242
or PDTC prevented such increases, whereas stimulation of
TLR4 using LPS up-regulated TLR4 expression synergistic-
ally (P < .05). The quantifications of TLR4 expressions were
shown in Figure 6B and F.
As shown in Figure 4, the data suggested that the num-
ber and dense of Iba-1-TLR4-postive punctuated dots in
group pretreated with PDTC were comparably to those in
groups receiving minocycline and TAK-242 at above time
points (P > .05). Thus, we further examine whether NF-κB
pathway was involved in the up-regulation of TLR4. The
immunofluorescent stain and quantitative results in
Figure 7A and B showed that I/R led to a significantincrease in NF-κB expression. Presence of LPS during I/R
synthetically up-regulated NF-κB, whereas this effect was
abrogated with TAK-242 treatment which inhibits TLR4
function (P < .05). Furthermore, pretreated rats with min-
ocycline, TAK-242 or PDTC decreased the number of
double-labeled cells (Figure 7B, P > .05) and TLR4 immu-
noreactivity (Figure 7C, P > .05).
Next, we evaluated the nuclear and cytoplasmic NF-κB
p65 expressions respectively to investigate the cellular
mechanisms which might attenuate the development of I/R.
Quantification of NF-κB p65 after normalized to Histone
and GAPDH in each sample were shown in Figure 6 C and
D. The data demonstrated that I/R significantly activated
NF-κB p65 in nuclear fractionation. Specifically, NF-κB p65
in I/R group increased by 1.105-fold and 1.234-fold relative
to Histone at 12 and 36 h after injury respectively (Figure 6C,
Figure 6 Alterations in TLR4 and NF-κB protein and mRNA expressions after spinal cord ischemia reperfusion (I/R) injury. (A)
Representative immunoblots were probed with antibody against TLR4 and NF-κB p65, while antibody against Histone and GAPDH served as loading
control for the nuclear and cytoplasmic protein, respectively. (B-E) Quantification of the densities of TLR4 (B), NF-κB p65 bands in nuclear extracts
(C), cytoplasmic extracts (D) and calculated as nucleocytoplasmic ratio (E) in different protocol conditions. The protein expression is presented in
relative units. (F-G) Real-time PCR analysis was performed in duplicate for TLR4 and NF-κB p65 under study and normalized to GAPDH mRNA.
(H) Quantification data of IL-1β production in the spinal cord at 12 h and 36 h after I/R injury, as assessed by ELISA. Ordinate represents the mean
integral density values (IDVs) ratios relative to the loading control. I/R caused significant increases in TLR4, nuclear and cytoplasmic NF-κB p65 expressions,
as well as nucleocytoplasmic ratio at 12 h and 36 h after I/R after normalizing to Histone and GAPDH, consistent with results from real time-PCR. Intrathecal
injection with minocycline, TAK-242 and PDTC prevented NF-κB p65 upregulation in nucleocytoplasmic ratio, as the upregulated expressions of NF-κB p65
in nucleus and comparable expressions in cytoplasma. Contrarily, intrathecal injection with LPS synergistically increased the activation. IL-1β content was
changed accordingly with the mRNA and protein expressions of TLR4 and NF-κB by ELISA. All data are presented as mean ± SEM. **P< .01 compared to
Sham group; ##P< .05 compared to I/R group; && P< .05 compared to I/R + P group.
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was decreased by 0.866-fold and 0.867-fold relative to
GAPDH (Figure 6D, P < .05). Moreover, the results were fur-
ther supported by quantification of NF-κB p65 in nucleocy-
toplasmic ratio shown in Figure 6E. The results showed thatnucleocytoplasmic ratio in I/R group at 12 h and 36 h,
respectively increased by 1.297-fold and 1.428-fold relative
to sham group (P < .05), consistent with real time-PCR re-
sults (Figure 6G). Significantly, pretreated with minocycline
and TAK-242 only prevented these increase in nucleus
Figure 7 Double immunostaining of TLR4 with transcription factor nuclear factor κB (NF-κB) after spinal cord ischemia reperfusion (I/R)
injury. (A) Representative micrographs show the colocation of TLR4 (red) and NF-κB (green) at 12 h and 36 h after I/R injury. Arrows delineate
co-localization. Scale bars are 100 μm. (B) Histogram for quantification of co-localized cells (cells with yellow signals). (C) Quantification of the
TLR4 immunoreactivity is presented as average of three fluorescence intensity (FI) of three independent experiments. Double immunohistochemistry
showed NF-κB had similar profile as TLR4 immunoreactivity after I/R injury. The rats pretreated with minocycline, TAK-242, PDTC were suggested significantly
decreased TLR4 immunoreactivity after I/R and the number of TLR4- NF-κB-positive cells, whereas above effects synthetically increased in rats receiving LPS.
All data are presented as mean ± SEM (n = 8 per group). **P< .01 compared to Sham group; ##P< .05 compared to I/R group.
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these increase in both nucleus and cytoplasma (Figure 6C
and D, P < .05).
Furthermore, to verify the inflammatory signal down-
stream activation, we detected the inflammatory cyto-
kine IL-1β activation by ELISA. The data presented that
IL-1β was activated along with the activation of TLR4
and NF-κB (Figure 6H, P < .05). Pretreated with minocy-
cline, TAK-242 or PDTC inhibited such activation,
whereas stimulation of TLR4 using LPS enhanced IL-1β
content synergistically (P < .05).Discussion
Ischemia/reperfusion (I/R) injury of the spinal cord after
an operation on the thoracic aorta is an unpredictable,
however, disastrous complication. To the best of our
knowledge, the current study is the first to demonstrate
activation of TLR4 in microglia and we show TLR4 is
participates in inflammatory reactions in the blood–spinal
cord barrier (BSCB) after I/R injury. Early and sustained
microglial activation can be determined by the mRNA and
protein expression of the microglial surface markers, Iba-1.
The membrane-bound receptor TLR4 is also overexpressed
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36 h after I/R injury. In addition, intrathecal administration
of minocycline for 3 days before ischemia showed obvious
protective effects in the form of a decrease in I/R-induced
microglial activation, in BSCB disruptions, and in the pro-
duction of proinflammatory cytokines. Results from this
study also demonstrated that when administered in this
preemptive manner, intrathecal infusion of a TLR4 receptor
inhibitor, TAK-242, exhibits protective effects similar to
minocycline pretreatment results, whereas intrathecal
injection of LPS, a TLR4 agonist, exacerbates deleteri-
ous effects. Given that NF-κB is known to be activated
in the presence of TLR4, it is expected that the NF-κB
inhibitor,PDTC inhibit I/R-induced microglial activa-
tion via upregulating TLR4.
The I/R model used and the period observed were
referred to previous studies, in which the evolution of
inflammatory cytokine activation in the spinal cord peaks
between 24 and 48 h after reperfusion [5,6,16]. This model
is a reliable and stable animal model for studying neuro-
protective manipulations and molecular mechanisms in
the spinal cord. BSCB consists of a continuous capillary
endothelium with tight junctions between its cells, sur-
rounded by astrocytes and perivascular microglia. The in-
tact barrier can prevent vasogenic edema and pathological
effects on CNS by restricting access of molecules and cells
to the spinal cord under conditions of stroke and I/R
[17,18]. It is generally believed that inflammatory factors
play a critical role in leakage of BSCB as a result of aber-
rant vascular permeability due to dissociation of zonula
occludens-1 (ZO-1) from the cytoskeletal complex and
due to an increased level of matrix metalloproteinases
(MMPs) and tumor necrosis factor α (TNF-α) [5,6,17-19].
As demonstrated in our previous study, BSCB permeabil-
ity is altered in the course of spinal cord I/R injury, and
these changes could be measured using extravasation of
EB dye [5,6]. This damage may caused by inflammatory
processes and it may further exacerbate inflammation.
Recent evidence support the notion that microglia, com-
ponents of the immune system are activated and play an
important role in the initiation phase of I/R-induced neu-
rodegenerative and inflammatory processes. When trig-
gered by peripheral inflammation or nerve injury, spinal
microglia can be rapidly activated and can respond to the
neurotransmitters released by central terminals of primary
sensory neurons, such as glutamate, substance P, and
adenosine triphosphate. After that, the release from acti-
vated glial cells of a series of growth factors, chemokines,
regulatory cytokines as well as free radicals and other toxic
mediators such as IL-1β, TNF-α, prostaglandin E2, and re-
active oxygen species (ROS), results in activation of rapid
signal transduction cascades leading to either survival or
death of neurons [9,17]. Representative micrographs of
ionized calcium–binding adaptor molecule 1 (Iba-1) arecommonly used to quantify activated microglia. Upon ac-
tivation, microglial cells transform from the ramified
shape to rounded (amoeboid) macrophage-like morph-
ology [20]. There are significantly greater numbers of Iba-
1–positive cells in the I/R group both at 12 and 36 h in
comparison to the lower numbers in the sham group.
Furthermore, the colocalization with TLR4 according to
double-immunofluorescence analysis confirmed that TLR4
is indeed upregulated in activated microglial cells in injured
regions of the spinal cord.
There are substantial protective effects of minocycline
(a member of the tetracycline antibiotic family), which
prevent microglial activation and generation of glutamate,
IL-1β, and nitric oxide (NO) [21]. To explore the role of
microglia in BSCB disruption after I/R injury, minocycline
was infused intrathecally during 3 days before the surgical
procedure in the present study. We also found that inhib-
ition of microglial activation by minocycline is accompanied
by a decreased number of Iba-1–positive cells.
Blamire et al. [22] and van Vliet et al. [23] examined
the role of proinflammatory cytokines in BSCB leakage.
These investigators reported that increased plasma levels
of inflammatory cytokines (such as IL-1β and IL-6) in
residual microglia (where disruption of the blood–brain
barrier occurred) might also be responsible for BSCB leak-
age. At the same time, we observed another protective
role of minocycline: it seems to attenuate (1} the BSCB
disruption as measured by EB extravasation and (2} an
increase in spinal water content. Our data show that min-
ocycline decreases the number of Iba-1–positive cells at
12 and 36 h after reperfusion and attenuates upregulation
of the proinflammatory molecules IL-1β and NF-κB in the
spinal cord. These findings were corroborated by previous
studies not only in experiments with ischemia [3,4]
but also in studies of systemic proinflammatory states
[9,23,24]. These observations suggest that activated micro-
glia may potentiate damage to BSCB components, which
is caused at least in part by proinflammatory cytokines.
Previously, we elucidated the molecular mechanisms
underlying inflammatory and immunological processes
of microglial activation after I/R. Upon activation,
microglial cells start to express TLR2–4 on their surface
[11,14]. Among diverse TLRs, it has been reported that
TLR4 enables microglia to induce immune and inflam-
matory responses and to release massive amounts of
proinflammatory cytokines via activation of NF-κB, once
TLR4 binds to its endogenous or exogenous ligands.
Studies show that TLR4-deficient mice display signifi-
cantly attenuated behavioral hypersensitivity and are
characterized by weaker spinal glial activation and low-
ered release of proinflammatory cytokines [8,12,14].
There is usually no viral or bacterial infection in I/R
models; recent research supports the notion that upreg-
ulated expression of TLR4 is implicated in activation of
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less, there is still debate and controversy regarding the
role of microglial TLR4 in the spinal cord during the earli-
est stage (<3 days) after I/R, where TLR4 must be involved
in various signal transduction pathways. Our results show
that early, robust, and sustained microglial activation after
I/R injury is characterized by a marked long-term induc-
tion of the TLR4 expression at protein and mRNA levels,
matching the pattern of immunostaining with Iba-1. In
parallel, cytokines IL-1β are released in the spinal cord
between 12 and 36 h after reperfusion, the finding that is
consistent with the above reports. We also confirmed the
specificity and the role of TLR4 in the microglial activation
and in inflammatory reactions induced by intrathecal infu-
sion of TLR4 receptor antagonists or agonists. We found
that downregulation of TLR4 receptor by TAK-242 lowers
the amount of resident microglial activated cells, decreases
levels of NF-κB translocation, and consequently downre-
gulates the cytokine IL-1β in the spinal cord between 12
and 36 h after reperfusion. Because TLR4 is a known
specific receptor for Gram-negative bacterial components
(LPS), the rats treated with LPS showed aggravated inflam-
matory processes, and BSCB disruption occurred in the I/R
region, in keeping with the pattern of upregulated TLR4.
In view of the pivotal role of TLR4 in microglial activa-
tion in the initial phase of I/R injury, the question arises
how TLR4 mediates microglial activation in spinal cord
I/R injury. After activation of the TLR4 signaling path-
way, NF-κB relocates to the nucleus and regulates
expression of target inflammatory genes via modulation
of both MyD88 or MyD88 adaptor–like adaptor protein
and TIR domain–containing adaptor [12,16,25]. With
double immunofluorescence in present study, we pro-
vided evidence that NF-κB signaling pathway activated
by TLR4 receptor played important roles in regulating
immune and inflammatory responses after I/R. We de-
tected greatly upregulation of NF-κB and IL-1β (at the
mRNA and protein level) in spinal cords limited to the
ischemic region between 12 and 36 h after I/R injury
and was accompanied with a selective increase in TLR4
expression. Pyrrolidine dithiocarbamate (PDTC) is a low-
molecular-weight thiol compound, was initially regarded as
a potent inhibitor of NF-κB by inhibiting factor I-κB phos-
phorylating, thus preventing the dissociation of the NF-κB
-IκB complex and interfering with the generation of proin-
flammatory cytokines [26-28]. It has been reported that
intrathecal PDTC can delay and reverse mechanical allody-
nia in several neuropathic pain conditions [27]. Similarly,
in present study, intrathecal infusion of PDTC was ob-
served to have suppressive effects on mechanical allodynia,
BSCB dysfunction and microglial activation as well as up-
regulated TLR4 mRNA and protein expressions in spinal
cord, suggesting that the activity of NF-κB pathway could
regulate spinal cord I/R injury via regulating TLR4.Neurons play very important roles in the nervous
system, involved in the processes of memory, sense and
behavior. A result of I/R-induced neurological deficit was
partly contributed to apoptosis of neurons in spinal cord
as reported in our previous studies [2,5,6]. Our data of
NeuN immunoreactivity sufficiently evidenced I/R lead to
a decrease neuron number in ventral gray matter and
increase percentage of double-labeled cells with cleaved
capase3, which referred as a mark of apoptosis. Mean-
while, microglia may release various factors to support
and guide the transfer of neurons, participate in neu-
rons repair and regeneration [29,30]. IL-1β is one of the
final inflammatory molecules produced in TLR4 signal-
ing pathway, which elicits a cascade of activation of cy-
tokines and multiple biological effects [22]. In a variety
of inflammatory conditions, reasonable upregulation of
IL-1β has been shown to limit extreme inflammatory
responses, with a possibility of rapidly activated phago-
cytosis of dead or dying cells to prevent a release of a
cascade of proinflammatory cytokines and to resolve in-
flammation. Nevertheless, excess IL-1β can significantly
worsen inflammation and tissue injury [9,13,22]. Thus,
these signals should be regulated very tightly to balance
proinflammatory and anti-inflammatory pathways. Bri-
kos and colleagues found that the cytoplasmic portion
of TLRs, called the Toll/IL-1 receptor (TIR) domain is
highly similar to that of the IL-1 receptor family [1].
Our study confirmed that IL-1β expression and loss
and apoptosis of neurons triggered by TLR4/ NF-κB
signal in spinal cord were strongly increased by intra-
thecal infusion of LPS; in contrast, the expression levels
were much lower in rats treated with minocycline,
TAK-242 or PDTC, indicating that there might be a posi-
tive feedback circuit. In other words, the expression of in-
flammatory cytokines is regulated by TLR4 in microglia,
and in turn, inflammatory cytokines can cause microglial
activation by amplifying and maintaining inflammatory
response via the TLR4 pathway. This notion also offers a
probable reason for the difficulty in developing an effect-
ive therapy for spinal cord injury–related complications.
Interestingly, the similar findings have been reported by
Bell at al in a mice model of aortic cross-clamping,
recently [31]. That study showed that inhibition of TLR4-
mediated microglial activation may be a major mechanism
of neuroprotection associated with the anti-inflammatory
effects. Regarding the controversial effects of microglial
activation via its plenty of membrane-bound receptors for
spinal cord recovery under different stimuli, further stud-
ies would be required to clarify the complicated role of
microglial TLR4 signaling in models of I/R injury. As
potential therapeutic modalities, minocycline, TAK-242
and PDTC would need further research, including safety
testing; for example, their effects on learning and memory
are unknown.
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microglial activation and proliferation via the TLR4–
microglia–NF-κB/IL-1β pathway result in protective effects
in some neurological deficits, hence, fortifying BSCB in-
tegrity, and reducing spinal cord swelling.
Conclusion
Taken together, our data provide evidence to support the
involvement of TLR4 signaling in modulation of microglia
activation in spinal cord I/R injury. We also suggest that
TLR4–microglia– NF-κB/IL-1β pathway as a positive feed-
back loop in the spinal dorsal horn after I/R injury; this
pathway is capable of exacerbating inflammatory reactions
and BSCB dysfunction. It could offer new therapeutic tar-
gets for managing severe and persistent complications of
spinal cord injury caused by I/R.
Materials and methods
Experimental animals
All experimental procedures were approved by the Ethics
Committee of China Medical University and were in com-
pliance with the Guide for the Care and Use of Laboratory
Animals (U.S. National Institutes of Health publication
No. 85–23, National Academy Press, Washington DC,
revised 1996). Male Sprague–Dawley rats, weighting 200–
250 g were used in this study. All rats were maintained
under standard condition throughout the experimental
period. Either motor or sensory dysfunction was observed
in rats that intrathecally received minocycline, lipopoly-
saccharide (LPS), TLR4 inhibitor (TAK-242), pyrrolidine
dithiocarbamate (PDTC) or saline before the induction of
ischemia.
Experimental I/R spinal cord injury
The spinal cord I/R model was induced by occlusion of
the aortic arch for 14 minutes, as previously reported
[16].All rats were anaesthetized with intraperitoneal
injection of 4% sodium pentobarbital at an initial dose of
50 mg/kg. Lung ventilation was achieved using a mouse
ventilator (Hollinston, MA) with endotracheal intubation.
Body temperature was continuously monitored with a rec-
tal probe and was maintained at 37.5 ± 0.5°C with the aid
of a heated operating table. A catheter was inserted into
the left carotid artery and into the tail artery to measure
proximal and distal blood pressure (Spacelabs Medical
Inc., Redmond, WA, USA). Under direct visualization, the
aortic arch was cross-clamped between the left common
carotid artery and the left subclavian artery. A catheter
was inserted into the left carotid artery and into the tail ar-
tery to measure proximal and distal blood pressure. Ische-
mia was confirmed as a 90% decrease in flow measured
at the tail artery by a laser Doppler blood flow monitor
(Moor Instruments, Axminster, Devon, UK) for 14 min,
after which, the clamp was removed and 36 h ofreperfusion took place. Sham operation rats underwent
the same procedure, but no occlusion of the aortic arch
was performed.
The experimental protocol
One hundred twenty rats were randomly assigned to 1
of 6 groups by means of a random number table: the I/R
group (n = 24), I/R + minocycline (I/R + M) group (n =
24), I/R + lipopolysaccharide (I/R + L) group (n = 24), I/
R + TLR4 inhibitor (TAK-242, I/R + T) group (n = 24),
I/R + pyrrolidine dithiocarbamate (PDTC, I/R + P) group
(n = 24) or the sham group (n = 24). Spinal cord I/R
injury was induced by occlusion of the aortic arch for
14 min, whereas the aorta was exposed, but without
occlusion in the sham group. In all groups, we per-
formed intrathecal infusion of 10 μL normal saline,
10 nmol/μL minocycline (10 μL, Nichiiko, Toyama,
Japan), 1 nmol/μL LPS (10 μL, Sigma; E. coli 011:B4),
10 nmol/μL TAK-242 (10 μL, EMD, Millipore; CAS
243984-11-4), 100 pmol/μL PDTC (10 μL, Sigma-
Aldrich, Mo;71935) or 10 μL of saline respectively,
continuously for 3 days before the surgical operation.
The rats were euthanized 12 and 36 h after the surgical
procedure. At each time point, animals were anesthe-
tized with an overdose of pentobarbital and the L4–6
segments of spinal cords were rapidly collected for ana-
lysis because of their vulnerability to ischemic injury.
Behavioral analysis
To quantify mechanical allodynia, the withdrawal
threshold of a hind-limb paw was assessed using von
Frey filaments (Stoelting Co., Wood Dale, IL, USA) and
the Dixon up–down method as described by Chaplan
and coworkers [32]. All behavioral tests were performed
before the surgical procedure (baseline) and at 12-h in-
tervals during a 36-h observation period by an observer
who was blinded to the experimental procedures.
Measurement of spinal cord edema
Water content of the spinal cord was measured by means
of the wet–dry method as quantitative measurement of
edema, as reported previously [5,6]. The percent water con-
tent was calculated using the following formula: %H2O=
(wet weight − dry weight) × 100/wet weight.
Measurement of Evans blue extravasation
After survival of rats for 12 and 36 h, Evans blue (EB)
content and EB fluorescence were used for quantitative
and qualitative analysis of BSCB disruption after spinal
cord I/R injury, as described previously [5,6]. Briefly, EB
at 30 g/L (45 mg/kg; Sigma) was slowly intravenously
injected into the tail vein 60 min before euthanasia.
After being adequately perfused with saline under deep
anesthesia, the L4–6 segment was removed and soaked in
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content was measured as absorbance of the supernatant
at 632 nm on a microplate reader (BioTek, Winooski,
VT) and calculated as the amount of EB per wet tissue
weight (μg/g). For measurement of the fluorescence,
the tissue was fixed in 4% paraformaldehyde, sectioned
(10 μm), and kept frozen and sealed in a light-tight con-
tainer. EB staining was visualized using a BX-60 (Olympus,
Melville, NY) fluorescence microscope (green filter). Per-
centage of recognized area (fluorescence intensity above the
threshold) referred to the whole image area was performed
using Image J software (NIH Image, Bethesda, MD).
Iba-1 immunoreactivity
Microglia were stained using an antibody against the
microglial marker, ionized calcium–binding adaptor mol-
ecule 1 (Iba-1) as described previously [17,32]. Briefly, the
sections were firstly blocked with 10% bovine serum albu-
min for 1 h at room temperature. After that, the sections
were incubated with a primary rabbit anti–Iba-1 antibody
(1:800: Wako, 019–19741) at 4°C overnight. After incuba-
tion with an Alexa 488–conjugated donkey anti–rabbit
IgG antibody (1:500; Molecular Probes, Rockford, USA)
for 1 h, the stained sections were examined under a
microscope (Carl Zeiss Axio Observer Z1, Jena, Germany)
determined the number of immunoreactive cells in the
medial superficial dorsal horn (laminae I–III). Nonspecific
staining was determined by omitting the primary anti-
body. The data were calculated as average numbers of
positive cells per area of a spinal section ± standard error
of the mean (SEM).
Double immunofluorescence
Double immunofluorescence analysis was carried out to
confirm the expression of TLR4 in microglia and
explored the relationship with NF-κB signal pathway
and neuroapoptosis after I/R [5,32]. Briefly, spinal cord
was fixed and sectioned into 10-μm slices with a Leica
CM3050 S cryostat. The sections were blocked with 10%
bovine serum albumin (BSA) for 1 h at room temperature
and incubated overnight at 4°C with the primary anti-
bodies: mouse anti-TLR4 (1:100, Abcam), mouse anti-
cleaved caspase3 (1:400, Cell signal technology), rabbit
anti-Iba-1 antibody (1:800, Wako), rabbit anti-NF-κB p65
(1:500, Abcam), rabbit anti-NeuN (1:800, Abcam). After in-
cubation with Alexa 594-conjugated donkey anti-mouse
IgG (1:500, Molecular Probes) and Alexa 488-conjugated
donkey anti-rabbit IgG (1:500, Molecular Probes) for 2 h at
room temperature. Each of the steps above was followed
by four rinses 5–10 min each in PBS containing 10% BSA
and 0.25% Triton X-100. Images were captured using a
Leica TCS SP2 (Leica Microsystems, Buffalo Grove, IL,
USA) laser scanning microscope and photographed by
the attached digital camera to determine the number ofimmunoreactive cells. Nonspecific staining was determined
by omitting the primary antibody. The data were expressed
as numbers of positive cells/area/spinal section ± standard
error mean (SEM).
Measurement of IL-1β using ELISA
The spinal cord was collected and homogenized,
followed by centrifugation. The IL-1β content was deter-
mined using an ELISA kit (R&D Systems, Minneapolis,
MN, US). According to the manufacturer’s instructions,
absorbance (A) was quantified at λ = 450 nm. The IL-1β
content of each sample was calculated based on the
standard curve, and IL-1β concentration was expressed
in pg/mg protein.
Western blots
The protein expression of TLR4 and NF-κB p65 in
spinal cord tissue was determined using Western blot-
ting analysis. The rats’ spinal cords were homogenized
and nuclear and cytoplasmic extracts was purified from
each specimen by using Nucleoprotein and cytoplasmic
protein extraction kit according to the manufacturer’s
instructions (KGP-150; KangChen, Shanghai, China).
The antibodies used in this experiment were mouse
monoclonal anti-TLR4 (Abcam), rabbit polyclonal anti–
NF-κB p65 (phospho S536, Abcam), mouse monoclonal
anti–Histone (Abcam) and anti-mouse GAPDH (dilution
1:10,000, Abcam) overnight on a shaker at 4°C.After three
washes with TBS-0.1% Tween, the membranes were incu-
bated with horseradish peroxidase-conjugated secondary
antibodies(Bioss, Beijing, China) for 1 h. Semiquantitation
of scanned images was performed using Quantity One
software (Bio-Rad Laboratories, Milan, Italy).
Real-time PCR
Quantitative real-time PCR was performed as described
previously [20,21]. Total RNA was extracted from L4–6
spinal cord tissue using the TRIzol reagent (Invitrogen–
Life Technologies), following the manufacturer’s instruc-
tions. PCR was performed as described previously using
a SYBR Green SuperMix-UDG and was conducted on a
Prism 7000 detection system (Applied Biosystems, Foster
City, CA). The following primers were used; TLR4
(NM_0191178, 127 bp): forward 5′-GGATGATGCCTCT
CTTGCAT-3′, reverse 5′-TGATCCATGCATTGGTAGG
TAA-3′; NF-κB (HL26267H): forward 5′-CTTCTCGGAG
TCCCTCACTG-3′, reverse 5′-CCAATAGCAGCTGGAA
AAGC-3′; and GAPDH (HNM_023964H, 238 bp): forward
5′-AGAAGGCTGGGGCTCATTTG-3′, reverse 5′-AGG
GGCCATCCACAGTCTTC-3′. Amplification was per-
formed using the following cycling conditions: 50°C for
2 min (uracil-DNA glycosylase incubation), 95°C for
10 min, followed by 40 cycles of denaturing at 95°C for
15 seconds and annealing at 60°C for 30 seconds. All
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was calculated relative to the endogenous control samples
(GAPGH) to obtain a relative quantity (RQ) value (2-ΔΔCt,
where CT is the threshold cycle).Statistical analysis
All data were collected by investigators blinded to surgery
status of the rats. The data were calculated as mean ±
SEM and analyzed using the SPSS software (version 17.0,
SPSS Inc., Chicago, IL, USA). The statistical data were
processed with one-way analysis of variance (ANOVA)
followed by Newman–Keuls post hoc analysis. Differences
with a P value of <0.05 were considered statistically sig-
nificant (Additional file 1: Figure S1).Additional file
Additional file 1: Figure S1. Western blotting analysis of transcription
factor NF-κB proteins in each group of spinal cords after I/R injury. (A)
Representative immunoblots were probed with antibody against NF-κB
p65, while antibody against Histone and GAPDH served as loading
control for the nuclear and cytoplasmic fraction, respectively. (B-D)
Quantification of the densities of NF-κB p65 bands in nuclear extracts (B),
cytoplasmic extracts (C) and calculated as nucleocytoplasmic ratio (D) in
different protocol conditions at 12h and 36h after I/R injury. The protein
expression is presented in relative units. (E-F) Quantification of the
densities of p-NF-κB p65 and p-I-κB in total protein, while anti-NF-κB p65
and anti-I-κB served as the corresponding loading controls at 12 and
36 h after injury. Ordinate represents the mean integral density values
(IDVs) ratios relative to the loading control. The data are presented as
mean ± SEM. **P < .01 compared to Sham group; ##P < .05 compared to
I/R group;&& compared to I/R+P group. I/R caused significant increases in
nuclear and cytoplasmic NF-κB p65 expressions, as well as nucleocytoplasmic
ratio at 12h and 36 h after I/R after normalizing to Histone and GAPDH,
respectively. The results were consistent with the changes of phosphorylation
of NF-κB and I-κB in total protein of spinal cord’s homogenates. Intrathecal
injection with minocycline, TAK-242 and PDTC attenuated I/R-induced NF-κB
p65 activation manifested as the decreased nuclear NF-κB p65, phosphorylation
of NF-κB p65 and I-κB in total protein as well as NF-κB p65 in nucleocytoplasmic
ratio at both timepoints, whereas injection with LPS synergistically increased the
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